Gossypol Interferes with Both Type I and Type II Topoisomerase Activities Without Generating Strand Breaks

Cell Biochemistry and Biophysics

Volumn 66, Issue 1, 2013, Pages 199-204

  Senarisoy, Muge ^a   Canturk, Pakize ^a   Zencir, Sevil ^b   Baran, Yusuf ^c   Topcu, Zeki ^a  

^a EGE UNIVERSITY   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

^c IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

Author keywords

Anticancer drug research; DNA strand breaks; DNA topoisomerases; Gossypol

Indexed keywords

MAMMALIA;

EID: 84876183776     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9468-5     Document Type: Article

References (23)

1. Wang, Y. C., & Rao, P. N. (1984). Effect of gossypol on DNA synthesis and cell cycle progression of mammalian cells in vitro. Cancer Research, 44, 35-38.
2. Moon, D. O., Choi, Y. H., Moon, S. K., Kim, W. J., & Kim, G. Y. (2011). Gossypol decreases tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression via suppression of NF-κB activity. Food and Chemical Toxicology, 49, 999-1005.
3. Huang, Y. W., Wang, L. S., Chang, H. L., Ye, W., Sugimoto, Y., Dowd, M. K., et al. (2006). Effects of serum on (-)-gossypol-suppressed growth in human prostate cancer cells. Anticancer Research, 26, 3613-3620.
4. Volate, S. R., Kawasaki, B. T., Hurt, E. M., Milner, J. A., Kim, Y. S., White, J., et al. (2010). Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells. Molecular Cancer Therapeutics, 9, 461-470.
5. Olgiati, K. L., & Toscano, W. A., Jr. (1983). Kinetics of gossypol inhibition of bovine lactate dehydrogenase X. Biochemical and Biophysical Research Communications, 115, 180-185.
6. Baumgrass, R., Weiwad, M., Erdmann, F., Liu, J. O., Wunderlich, D., Grabley, S., et al. (2001). Reversible inhibition of calcineurin by the polyphenolic aldehyde gossypol. Journal of Biological Chemistry, 276, 47914-47921.
7. Adlakha, R. C., Ashorn, C. L., Chan, D., & Zwelling, L. A. (1989). Modulation of 4′-(9-acridinylamino) metanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol. Cancer Research, 49, 2052-2058.
8. Wang, J. C. (1996). DNA topoisomerases. Annual Review Biochemistry, 65, 635-692.
9. Topcu, Z. (2001). DNA topoisomerases as targets for anticancer drugs. Journal of Clinical Pharmacy and Therapeutics, 26, 405-416.
10. Wang, J. C. (2002). Cellular roles of DNA topoisomerases: a molecular perspective. Nature Reviews, 3, 430-440.
11. D'Arpa, P., & Liu, L. F. (1989). Topoisomerase-targeting antitumor drugs. Biochimica et Biophysica Acta, 989, 163-177.
12. Hsiang, Y. H., & Liu, L. F. (1988). Identification of mammalian topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Research, 26, 1722-1726.
13. Sordet, O., Khan, Q. A., & Pommier, Y. (2004). Apoptotic topoisomerase I-DNA complexes induced by oxygen radicals and mitochondrial dysfunction. Cell Cycle, 3, 1095-1097.
14. Galvez, M., Martín-Cordero, C., & Ayuso, M. J. (2005). Iridoids as DNA topoisomerase I poisons. Journal of Enzyme Inhibition and Medicinal Chemistry, 20, 389-392.
15. Ishar, M. P., Singh, G., Singh, S., Sreenivasan, K. K., & Singh, G. (2006). Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents. Bioorganic & Medicinal Chemistry Letters, 16, 1366-1370.
16. Kucukoglu, O., Ozturk, B., Kamataki, T., & Topcu, Z. (2006). Inhibitory activities of Helichrysum taxa on mammalian type I DNA topoisomerase. Pharmaceutical Biology, 44, 189-193.
17. Alpan, S., Gunes, S., & Topcu, Z. (2007). 1H-Benzimidazole derivatives as mammalian DNA topoisomerase I inhibitors. Acta Biochimica Polonica, 54, 561-565.
18. Canturk, P., Kucukoglu, K., Topcu, Z., Gul, M., & Gul, H. I. (2008). Effect of some bis-Mannich bases and corresponding piperidinols on DNA topoisomerase I. Arzneimittel Forschung, 58, 686-691.
19. Topcu, Z., Ozturk, B., Kucukoglu, O., & Kilinc, E. (2008). Flavonoids in Helichrysum pamphylicum inhibit mammalian type I DNA topoisomerase. Zeitschrift für Naturforschung C, 63, 69-74.
20. Coban, G., Zencir, S., Zupkó, I., Réthy, B., Gunes, H. S., & Topcu, Z. (2009). Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays. European Journal of Medicinal Chemistry, 44, 2280-2285.
21. Sarikaya, D., Bilgen, C., Kamataki, T., & Topcu, Z. (2006). Comparative cytochrome P450-1A1, -2A6, -2B6, -2C, -2D6, -2E1, -3A5 and -4B1 expressions in human larynx tissue analysed at mRNA level. Biopharmaceutics & Drug Disposition, 27, 353-359.
22. Mete, E., Gul, H. I., Canturk, P., & Topcu, Z. (2010). Biological activity of 1-aryl-3-phenethylamino-1-propanone hydrochlorides and 3-aroyl-4-aryl-1-phenethyl-4-piperidinols on PC-3 cells and DNA topoisomerase I enzyme. Zeitschrift für Naturforschung C, 65, 647-652.
23. Marini, J. C., Miller, K. G., & Englund, P. T. (1980). Decatenation of kinetoplast DNA by topoisomerases. Journal of Biological Chemistry, 255, 4976-4979.